Bioventus (BVS) News Today $10.04 -0.07 (-0.69%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period JPMorgan Chase & Co. Raises Position in Bioventus Inc. (NYSE:BVS)JPMorgan Chase & Co. lifted its holdings in shares of Bioventus Inc. (NYSE:BVS - Free Report) by 228.3% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 253,740 shares of the company's stock after purchasing an additionalJanuary 20 at 3:14 AM | marketbeat.comRobert E. Claypoole Sells 28,786 Shares of Bioventus Inc. (NYSE:BVS) StockBioventus Inc. (NYSE:BVS - Get Free Report) CEO Robert E. Claypoole sold 28,786 shares of the business's stock in a transaction on Monday, January 13th. The stock was sold at an average price of $9.10, for a total value of $261,952.60. Following the sale, the chief executive officer now owns 64,964 shares of the company's stock, valued at approximately $591,172.40. The trade was a 30.71 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.January 14, 2025 | marketbeat.comBioventus to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 7, 2025 | markets.businessinsider.comCraig-Hallum Issues a Buy Rating on Bioventus (BVS)January 7, 2025 | markets.businessinsider.comBioventus (NYSE:BVS) Trading Down 5.9% - Here's WhyBioventus (NYSE:BVS) Trading Down 5.9% - Should You Sell?January 6, 2025 | marketbeat.comBioventus: Amply Rewarded For Recent ProgressJanuary 5, 2025 | seekingalpha.comBioventus, Inc.: Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed PartnersJanuary 3, 2025 | finanznachrichten.deBioventus completes divestiture of its Advanced Rehabilitation businessJanuary 3, 2025 | markets.businessinsider.comBioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed PartnersJanuary 2, 2025 | globenewswire.comBioventus Inc. (NYSE:BVS) Shares Purchased by Geode Capital Management LLCGeode Capital Management LLC increased its holdings in shares of Bioventus Inc. (NYSE:BVS - Free Report) by 7.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 940,496 shares of the company's stock aftJanuary 1, 2025 | marketbeat.comFranklin Resources Inc. Takes $1.01 Million Position in Bioventus Inc. (NYSE:BVS)Franklin Resources Inc. purchased a new position in Bioventus Inc. (NYSE:BVS - Free Report) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 80,412 shares of the company's stock, valued at approximately $1,011,000.December 29, 2024 | marketbeat.comState Street Corp Has $8.08 Million Stock Holdings in Bioventus Inc. (NYSE:BVS)State Street Corp grew its holdings in shares of Bioventus Inc. (NYSE:BVS - Free Report) by 38.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 676,501 shares of the company's stock after buying an additional 189December 28, 2024 | marketbeat.comInsider Selling: Bioventus Inc. (NYSE:BVS) SVP Sells 2,535 Shares of StockDecember 27, 2024 | insidertrades.comKatrina J. Church Sells 2,535 Shares of Bioventus Inc. (NYSE:BVS) StockBioventus Inc. (NYSE:BVS - Get Free Report) SVP Katrina J. Church sold 2,535 shares of the company's stock in a transaction dated Monday, December 23rd. The stock was sold at an average price of $10.53, for a total transaction of $26,693.55. Following the transaction, the senior vice president now owns 47,264 shares in the company, valued at approximately $497,689.92. This trade represents a 5.09 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.December 26, 2024 | marketbeat.comBioventus Inc. (NYSE:BVS) CFO Sells $113,018.49 in StockBioventus Inc. (NYSE:BVS - Get Free Report) CFO Mark Leonard Singleton sold 10,733 shares of the company's stock in a transaction on Monday, December 23rd. The stock was sold at an average price of $10.53, for a total transaction of $113,018.49. Following the transaction, the chief financial officer now owns 105,162 shares in the company, valued at approximately $1,107,355.86. The trade was a 9.26 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.December 26, 2024 | marketbeat.comShareholder lawsuit ends with $15 million settlementDecember 24, 2024 | bizjournals.comBioventus: Strategic Moves Amidst Financial Challenges Justify Hold RatingDecember 17, 2024 | markets.businessinsider.comJP Morgan Upgrades Bioventus (BVS)December 17, 2024 | msn.comBioventus (NYSE:BVS) Shares Gap Up - Here's WhyBioventus (NYSE:BVS) Shares Gap Up - Time to Buy?December 17, 2024 | marketbeat.comBioventus (NYSE:BVS) Upgraded at JPMorgan Chase & Co.JPMorgan Chase & Co. raised Bioventus from an "underweight" rating to a "neutral" rating and boosted their price objective for the stock from $12.00 to $13.00 in a report on Tuesday.December 17, 2024 | marketbeat.comFmr LLC Acquires 166,014 Shares of Bioventus Inc. (NYSE:BVS)Fmr LLC raised its holdings in shares of Bioventus Inc. (NYSE:BVS - Free Report) by 21,256.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 166,795 shares of the company's stock after purchasing an additioDecember 16, 2024 | marketbeat.comBioventus Inc. (NYSE:BVS) Shares Acquired by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. lifted its holdings in Bioventus Inc. (NYSE:BVS - Free Report) by 38.9% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 390,162 shares of the company's stock after purchasing an addiDecember 14, 2024 | marketbeat.comPoint72 Asset Management L.P. Acquires Shares of 65,974 Bioventus Inc. (NYSE:BVS)Point72 Asset Management L.P. bought a new position in shares of Bioventus Inc. (NYSE:BVS - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 65,974 shares of the company's stock, valued at approximDecember 12, 2024 | marketbeat.comJacobs Levy Equity Management Inc. Trims Stake in Bioventus Inc. (NYSE:BVS)Jacobs Levy Equity Management Inc. lowered its stake in Bioventus Inc. (NYSE:BVS - Free Report) by 34.4% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 195,608 shares of the company's stock after selling 102,407 shares duDecember 8, 2024 | marketbeat.com258,756 Shares in Bioventus Inc. (NYSE:BVS) Acquired by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Bioventus Inc. (NYSE:BVS - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 258,756 shares of the companyNovember 25, 2024 | marketbeat.comSegall Bryant & Hamill LLC Buys New Position in Bioventus Inc. (NYSE:BVS)Segall Bryant & Hamill LLC purchased a new position in Bioventus Inc. (NYSE:BVS - Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 377,824 shares of the company's stock, valued at approximately $4,515,000. Segall Bryant & Hamill LLC ownedNovember 23, 2024 | marketbeat.comRoyce & Associates LP Invests $8.34 Million in Bioventus Inc. (NYSE:BVS)Royce & Associates LP bought a new position in shares of Bioventus Inc. (NYSE:BVS - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 697,696 shares of the company's stock, valued at approximaNovember 18, 2024 | marketbeat.comLos Angeles Capital Management LLC Acquires Shares of 143,464 Bioventus Inc. (NYSE:BVS)Los Angeles Capital Management LLC bought a new position in shares of Bioventus Inc. (NYSE:BVS - Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 143,464 shares of the company's stock, vaNovember 14, 2024 | marketbeat.comBioventus Inc. (NASDAQ:BVS) Q3 2024 Earnings Call TranscriptNovember 8, 2024 | msn.comBioventus Inc (BVS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...November 6, 2024 | finance.yahoo.comQ3 2024 Bioventus Inc Earnings CallNovember 6, 2024 | uk.finance.yahoo.comBioventus (NYSE:BVS) Shares Gap Down - Here's What HappenedBioventus (NYSE:BVS) Shares Gap Down - Time to Sell?November 5, 2024 | marketbeat.comBioventus Inc. 2024 Q3 - Results - Earnings Call PresentationNovember 5, 2024 | seekingalpha.comBioventus (NYSE:BVS) Updates FY24 Earnings GuidanceBioventus (NYSE:BVS) updated its FY24 earnings guidance. The company provided EPS guidance of $0.40-0.42 for the period, compared to the consensus estimate of $0.39. The company also issued revenue guidance of $562-567 millionillion, compared to the consensus estimate of $561.76 millionillion.November 5, 2024 | marketbeat.comBioventus Reports Third Quarter Financial ResultsNovember 5, 2024 | globenewswire.comBioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Look ForNovember 4, 2024 | finance.yahoo.comBioventus (BVS) Set to Announce Quarterly Earnings on TuesdayBioventus (NYSE:BVS) will be releasing earnings before the market opens on Tuesday, November 5, Zacks reports.October 30, 2024 | marketbeat.comBioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024October 29, 2024 | globenewswire.comBioventus files to sell 35.04M shares of Class A common stock for holdersOctober 26, 2024 | markets.businessinsider.comBioventus files $200M mixed securities shelfOctober 26, 2024 | markets.businessinsider.comBioventus (NYSE:BVS) Sets New 1-Year High - Time to Buy?Bioventus (NYSE:BVS) Hits New 12-Month High - What's Next?October 23, 2024 | marketbeat.comBioventus (NASDAQ:BVS) Stock Quotes, Forecast and News SummaryOctober 19, 2024 | benzinga.comBioventus (NYSE:BVS) Reaches New 52-Week High - Still a Buy?Bioventus (NYSE:BVS) Hits New 52-Week High - Time to Buy?October 14, 2024 | marketbeat.comBioventus Inc. (NYSE:BVS) Shares Acquired by Dimensional Fund Advisors LPDimensional Fund Advisors LP increased its holdings in shares of Bioventus Inc. (NYSE:BVS - Free Report) by 100.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 117,496 shares of the company's stockOctober 14, 2024 | marketbeat.comBioventus (NYSE:BVS) Trading Up 7.5% - Here's What HappenedBioventus (NYSE:BVS) Shares Up 7.5% - Time to Buy?October 11, 2024 | marketbeat.comBioventus Inc (BVS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...October 10, 2024 | finance.yahoo.comDurham public company inks $45M deal to divest business unitOctober 8, 2024 | bizjournals.com133,641 Shares in Bioventus Inc. (NYSE:BVS) Acquired by Bank of Montreal CanBank of Montreal Can acquired a new stake in shares of Bioventus Inc. (NYSE:BVS - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 133,641 shares of the company's stock, valued at apOctober 8, 2024 | marketbeat.comMarshall Wace LLP Has $1.91 Million Stock Holdings in Bioventus Inc. (NYSE:BVS)Marshall Wace LLP grew its stake in shares of Bioventus Inc. (NYSE:BVS - Free Report) by 38.2% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 332,291 shares of the company's stock after purchasing an additional 91,843 shOctober 5, 2024 | marketbeat.comBioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed PartnersOctober 1, 2024 | finance.yahoo.com Get Bioventus News Delivered to You Automatically Sign up to receive the latest news and ratings for BVS and its competitors with MarketBeat's FREE daily newsletter. Email Address BVS Media Mentions By Week BVS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BVS News Sentiment▼0.510.44▲Average Medical News Sentiment BVS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BVS Articles This Week▼32▲BVS Articles Average Week Get Bioventus News Delivered to You Automatically Sign up to receive the latest news and ratings for BVS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NovoCure News LivaNova News Warby Parker News Enovis News Tandem Diabetes Care News TransMedics Group News CONMED News LeMaitre Vascular News Soleno Therapeutics News InMode News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BVS) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventus Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioventus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BVS Stock Alerts